Eisler Capital (Us) LLC Pfizer Inc Call Options Transaction History

Eisler Capital (Us) LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $3.73 Million - $4.22 Million	-134,500 Reduced 72.16%	51,900 $1.5 Billion
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $4.11 Million - $4.82 Million	162,800 Added 689.83%	186,400 $5.22 Billion
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $3.04 Million - $3.49 Million	-117,300 Reduced 83.25%	23,600 $655 Million
Q4 2023 Feb 13, 2024	BUY	$26.13 - $33.94 $1.95 Million - $2.53 Million	74,600 Added 112.52%	140,900 $4.06 Billion
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $481,350 - $562,650	-15,000 Reduced 18.45%	66,300 $2.2 Billion
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $2.94 Million - $3.4 Million	81,300 New	81,300 $2.98 Billion

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Eisler Capital (Us) LLC, based on Form 13F filings with the SEC.

Stay updated on Eisler Capital (Us) LLC with notifications on news.